Exclusion of an extracolonic disease modifier locus on chromosome 1p33–36 in a large Swiss familial adenomatous polyposis kindred

[1]  P. Radice,et al.  Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  L. Lipton,et al.  Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. , 2003, The New England journal of medicine.

[3]  L. Siracusa,et al.  Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus , 2003, Mammalian Genome.

[4]  R. Houlston,et al.  Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes , 2002, Gut.

[5]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[6]  G. Ranzani,et al.  Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer‐related genes and correlates with stage and histology, but lacks independent prognostic value , 2002, The Journal of pathology.

[7]  Alison L. Livingston,et al.  Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.

[8]  I. Tomlinson,et al.  Variability in the severity of colonic disease in familial adenomatous polyposis results from differences in tumour initiation rather than progression and depends relatively little on patient age , 2001, Gut.

[9]  R. Fodde,et al.  Disease model: familial adenomatous polyposis. , 2001, Trends in molecular medicine.

[10]  J. Gebert,et al.  Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families , 2001, Gut.

[11]  S. Goodman,et al.  Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. , 2001, Cancer research.

[12]  I. Tomlinson,et al.  Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes , 2001, Gut.

[13]  T. Iwama,et al.  The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis. , 2000, Japanese journal of clinical oncology.

[14]  P. Rozen,et al.  Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APCmutation in exon 9 , 1999, Gut.

[15]  R. Fodde,et al.  Mechanisms of APC-driven tumorigenesis: lessons from mouse models , 1999, Cytogenetic and Genome Research.

[16]  J. Houwing-Duistermaat,et al.  The genetic background modifies the spontaneous and X‐ray–induced tumor spectrum in the Apc1638N mouse model , 1999, Genes, chromosomes & cancer.

[17]  S. Powell,et al.  Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene , 1998, Gut.

[18]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[19]  A Luz,et al.  Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. , 1998, Gastroenterology.

[20]  R. Fodde,et al.  Intestinal and extra-intestinal tumor multiplicities in the Apc1638N mouse model after exposure to X-rays. , 1997, Carcinogenesis.

[21]  Eric S. Lander,et al.  Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis , 1997, Nature Genetics.

[22]  R. Scott,et al.  Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis , 1997, Human Genetics.

[23]  W. Bodmer,et al.  Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours , 1996, Annals of human genetics.

[24]  M. Schwab,et al.  Genomic instability in Ip and human malignancies , 1996, Genes, chromosomes & cancer.

[25]  R. Scott,et al.  Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis , 1996, Human Genetics.

[26]  Scott E. Kern,et al.  Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers , 1996, Nature Genetics.

[27]  W. Bodmer,et al.  A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. , 1996, Journal of medical genetics.

[28]  Cécile Fizames,et al.  A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.

[29]  M. Miyaki,et al.  Sisters with familial adenomatous polyposis affected with thyroid carcinoma, desmoid tumour and duodenal polyposis , 1996, The British journal of surgery.

[30]  K. Kinzler,et al.  Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. , 1995, Cancer research.

[31]  Arthur M Buchberg,et al.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.

[32]  R. Scott,et al.  Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes. , 1995, Gut.

[33]  G. Petersen,et al.  Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. , 1994, Gastroenterology.

[34]  Cécile Fizames,et al.  The 1993–94 Généthon human genetic linkage map , 1994, Nature Genetics.

[35]  Jurg Ott,et al.  Handbook of Human Genetic Linkage , 1994 .

[36]  E. Lander,et al.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.

[37]  G. Gyapay,et al.  A second-generation linkage map of the human genome , 1992, Nature.

[38]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Gardner,et al.  Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. , 1953, American journal of human genetics.

[40]  S. Gallinger,et al.  Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma , 2004, Familial Cancer.

[41]  A. de la Chapelle,et al.  Hereditary colorectal cancer. , 2003, The New England journal of medicine.

[42]  L. Siracusa,et al.  Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. , 2002, Genome research.

[43]  H. Verspaget,et al.  Extracolonic manifestations of familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas. , 1998, Scandinavian journal of gastroenterology. Supplement.